Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

Polycystic Ovarian Syndrome (PCOS) is a common condition causing fertility issues and other symptoms, with unclear causes and treatments focused on improving insulin sensitivity.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

A new gene variant causes glucocorticoid resistance in a mother and son.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Hyperprolactinemia should be treated before confirming a PCOS diagnosis.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

The guidelines help doctors diagnose and treat hormone-related disorders in women.